Fundraising FoxAxial VC — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
ZymeCO creates enzyme-based bio-solutions that accelerate decomposition of organic matter in soil and turf, serving agriculture and golf course management.
AgTechBiotechImpact & Social GoodColorado Springs, US
Thaddaus Huber(Executive Officer, Director)Mark Slavens(CEO)
BoardRik Wehbring(Director)Michael Cantrell(Director)
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)inJoshua Yang(Founder)
BoardCraig Asher(Director)inJimmy Yun(Director)in
Co-investorsArtis VenturesBlack FlagCivilization Ventures Management, LlcFoundersX VenturesGaingelsHarpoon Ventures+10 more
__Twitter.png)
Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts.
AI & Machine LearningBiotechDeep TechHealthtechSeattle, US
Alex Federation(Founder)inLindsay Pino(Founder)inAlex Federation, Ph.D.(Chief Executive Officer & Co-Founder)Lindsay Pino, Ph.D.(Chief Technology Officer & Co-Founder)
BoardOmri Amirav-Drory(Director)inJ. Seth Strattan(Director)in
Co-investorsFarvatn VentureFifty YearsFundersClubGaingelsJude GomilaNFX+12 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.